292 related articles for article (PubMed ID: 35619312)
1. Role of Biological Mediators of Tumor-Associated Macrophages in Breast Cancer Progression.
Li Y; Ganesan K; Chen J
Curr Med Chem; 2022; 29(33):5420-5440. PubMed ID: 35619312
[TBL] [Abstract][Full Text] [Related]
2. The role of tumor-associated macrophage in breast cancer biology.
Choi J; Gyamfi J; Jang H; Koo JS
Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
[TBL] [Abstract][Full Text] [Related]
3. Role of chemokines in the crosstalk between tumor and tumor-associated macrophages.
Qin R; Ren W; Ya G; Wang B; He J; Ren S; Jiang L; Zhao S
Clin Exp Med; 2023 Sep; 23(5):1359-1373. PubMed ID: 36173487
[TBL] [Abstract][Full Text] [Related]
4. Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy.
Nie Y; Huang H; Guo M; Chen J; Wu W; Li W; Xu X; Lin X; Fu W; Yao Y; Zheng F; Luo ML; Saw PE; Yao H; Song E; Hu H
Clin Cancer Res; 2019 Jul; 25(13):3873-3886. PubMed ID: 30890553
[TBL] [Abstract][Full Text] [Related]
5. Role of Tumor-Associated Macrophages in Sarcomas.
Fujiwara T; Healey J; Ogura K; Yoshida A; Kondo H; Hata T; Kure M; Tazawa H; Nakata E; Kunisada T; Fujiwara T; Ozaki T
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33802565
[TBL] [Abstract][Full Text] [Related]
6. Regulation of tumor-associated macrophage (TAM) differentiation by NDRG2 expression in breast cancer cells.
Lee S; Lee A; Lim J; Lim JS
BMB Rep; 2022 Feb; 55(2):81-86. PubMed ID: 34743782
[TBL] [Abstract][Full Text] [Related]
7. Total glucosides of paeony inhibit breast cancer growth by inhibiting TAMs infiltration through NF-κB/CCL2 signaling.
Jin L; Guo Y; Mao W; Wang J; Jin L; Liu X; Shou Q; Fu H
Phytomedicine; 2022 Sep; 104():154307. PubMed ID: 35841664
[TBL] [Abstract][Full Text] [Related]
8. TFEB is a master regulator of tumor-associated macrophages in breast cancer.
Li Y; Hodge J; Liu Q; Wang J; Wang Y; Evans TD; Altomare D; Yao Y; Murphy EA; Razani B; Fan D
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32487570
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Associated Macrophages as Multifaceted Regulators of Breast Tumor Growth.
Munir MT; Kay MK; Kang MH; Rahman MM; Al-Harrasi A; Choudhury M; Moustaid-Moussa N; Hussain F; Rahman SM
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207035
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated macrophages in breast cancer: Innocent bystander or important player?
Qiu SQ; Waaijer SJH; Zwager MC; de Vries EGE; van der Vegt B; Schröder CP
Cancer Treat Rev; 2018 Nov; 70():178-189. PubMed ID: 30227299
[TBL] [Abstract][Full Text] [Related]
11. Interaction of tumor‑associated macrophages with stromal and immune components in solid tumors: Research progress (Review).
Kazakova A; Sudarskikh T; Kovalev O; Kzhyshkowska J; Larionova I
Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36660926
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive characterization of early-programmed tumor microenvironment by tumor-associated macrophages reveals galectin-1 as an immune modulatory target in breast cancer.
Chung H; Gyu-Mi P; Na YR; Lee YS; Choi H; Seok SH
Theranostics; 2024; 14(2):843-860. PubMed ID: 38169569
[No Abstract] [Full Text] [Related]
13. Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers.
Xu T; Yu S; Zhang J; Wu S
J Hematol Oncol; 2021 Oct; 14(1):181. PubMed ID: 34717710
[TBL] [Abstract][Full Text] [Related]
14. Targeting tumor-associated macrophages as an antitumor strategy.
Cheng N; Bai X; Shu Y; Ahmad O; Shen P
Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages: An important player in breast cancer progression.
Huang X; Cao J; Zu X
Thorac Cancer; 2022 Feb; 13(3):269-276. PubMed ID: 34914196
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer.
Li D; Ji H; Niu X; Yin L; Wang Y; Gu Y; Wang J; Zhou X; Zhang H; Zhang Q
Cancer Sci; 2020 Jan; 111(1):47-58. PubMed ID: 31710162
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy.
Khan SU; Khan MU; Azhar Ud Din M; Khan IM; Khan MI; Bungau S; Hassan SSU
Front Immunol; 2023; 14():1166487. PubMed ID: 37138860
[TBL] [Abstract][Full Text] [Related]
18. [Advances in the Study of Tumor-associated Macrophages in Lung Cancer].
Qiao Y; Fu E
Zhongguo Fei Ai Za Zhi; 2022 Jan; 25(1):34-39. PubMed ID: 35078283
[TBL] [Abstract][Full Text] [Related]
19. Unraveling the enigma of tumor-associated macrophages: challenges, innovations, and the path to therapeutic breakthroughs.
Shao S; Miao H; Ma W
Front Immunol; 2023; 14():1295684. PubMed ID: 38035068
[TBL] [Abstract][Full Text] [Related]
20. Targeting tumor exosomal circular RNA cSERPINE2 suppresses breast cancer progression by modulating MALT1-NF-𝜅B-IL-6 axis of tumor-associated macrophages.
Zhou B; Mo Z; Lai G; Chen X; Li R; Wu R; Zhu J; Zheng F
J Exp Clin Cancer Res; 2023 Feb; 42(1):48. PubMed ID: 36797769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
